菌血症の早期アウトカム予測モデルを作成~急性期医療に関わる臨床医にとって重要な新たな指標~

ad

2026-01-26 北海道大学

北海道大学 環境健康科学研究教育センターの岩田啓芳特任准教授らは、全国8病院・3大学が参加する多施設共同研究JA-BICAの後ろ向きコホートデータを用い、菌血症患者における抗菌薬治療開始72時間以内の早期治療不応(Early Antibiotic Treatment Failure:EATF)を予測する新たな臨床スコアモデルを開発した。本モデルは、患者背景や基礎疾患、感染症重症度に加え、治療開始後の臨床経過など、日常診療で routinely 取得される指標のみで構成されている点が特徴である。初期診療時の情報に限定せず、治療途中のデータを組み込むことで、早期に治療効果不十分例を見極め、治療方針変更や集中管理の判断を支援する。本成果は、急性期医療における菌血症診療の質向上に資する基盤的研究として位置づけられる。

菌血症の早期アウトカム予測モデルを作成~急性期医療に関わる臨床医にとって重要な新たな指標~
図 1. 当研究の予測モデルの性能を示す ROC 曲線。ROC:Receiver Operating Characteristic 曲線は診断モデルや予測モデルの性能を評価するための指標で、感度(見逃さない力)と特異度(誤認しない力)のバランスを視覚的に示す曲線。曲線が左上に近いほど、モデルの判別性能が高いことを示す。

<関連情報>

菌血症抗菌薬治療後早期臨床予測モデル Early prediction model for antibiotic treatment failure in bacteraemia: Japan bacteremia inpatient cohort association

H. Iwata ∙ M. Kaneko ∙ K. Kamada ∙ … ∙ S. Hamada ∙ T. Saito ∙ T. Aoki
Journal of Hospital Infection  Published:December 1, 2025
DOI:https://doi.org/10.1016/j.jhin.2025.11.031

Summary

Introduction

Early antibiotic treatment failure (EATF) is a clinically important concept but remains underrecognized among frontline physicians. Moreover, no validated prediction models currently exist that specifically target EATF in patients with bacteraemia. The present study aims to develop and internally validate a clinical prediction model for EATF in hospitalised adults with bacteraemia.

Methods

This multi-centre retrospective cohort study included adult inpatients with bacteremia from the Japan Bacteremia Inpatient Cohort Association, conducted across eight community hospitals in Japan from 2018 to 2022. Based on review results, we defined EATF as an outcome that included changes in antibiotics and advanced treatment after 72 h of admission. Using 28 candidate variables from previous studies, models and clinical expertise, we developed our model through backward elimination based on the Akaike Information Criterion. After constructing the score model, discrimination was assessed using the area under the curve (AUC), while calibration was evaluated using a plot. Internal validation used the bootstrap method to assess AUC and overfitting.

Findings

Among the 1084 eligible patients, 388 experienced EATF. The model included abnormal white blood cell count, low serum albumin, occlusive lesions, transfer admission and oxygen therapy. Internal validation demonstrated an AUC of 0.66, 95% confidence interval (0.62, 0.69) and a calibration slope of 1.01.

Conclusions

Although the model’s discrimination was modest, this study highlights the importance of EATF as a clinical outcome and demonstrates the inherent difficulty of developing predictive models for bacteraemia. External validation is warranted.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました